Equasens : Stifel maintains its recommendation on the share

Stifel maintains its 'hold' rating on Equasens shares, with an unchanged target price of €66. The analyst reports that Equasens has confirmed its long-awaited acquisition of AD Apotheken...

Related Keywords

Germany , German , , Ad Apotheken Datenverarbeitung Gmbh Co , Cercle Finance , Markets ,